Martin Purtscher

Takeda (Austria) — Austria

Immunology and Microbiology · Life Sciences

18h-index4.6kcitations22works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(10), Monoclonal and Polyclonal Antibodies Research(9), Protein purification and stability(5), HIV/AIDS drug development and treatment(4), Immune Cell Function and Interaction(4)

Publications22 total

On-column virus inactivation by solvent/detergent treatment for a recombinant biological product
Biologicals·2023· 3 citedOpen Access
BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.
PubMed·2012· 96 cited
Development of a Large Scale Production Process for BAX 855, a PEGylated rFVIII Product with Prolonged Half-Life
Blood·2011· 1 cited
Development of a plasma- and albumin -free recombinant von Willebrand factor
Hämostaseologie·2009· 59 citedOpen Access
Biochemical and Functional Characterization of a Serum-Free rVWF Drug Candidate.
Blood·2006· 2 cited
Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human periopherial blood lymphocytes.
PubMed·2002· 24 cited
A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1
AIDS Research and Human Retroviruses·2001· 512 cited
Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells
Biotechnology and Bioengineering·2000· 59 cited
Antibody Neutralization-Resistant Primary Isolates of Human Immunodeficiency Virus Type 1
Journal of Virology·1998· 72 citedOpen Access
A simple and robust method for the complete dissociation of HIV-1 p24 and other antigens from immune complexes in serum and plasma samples
Journal of Immunological Methods·1998· 35 cited
Immunogenic Presentation of a Conserved gp41 Epitope of Human Immunodeficiency Virus Type 1 on Recombinant Surface Antigen of Hepatitis B Virus
Journal of General Virology·1996· 121 cited
Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5
AIDS·1996· 162 cited
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
Journal of Virology·1996· 1.1k citedOpen Access
Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus
Journal of Virology·1995· 109 citedOpen Access
A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1
AIDS Research and Human Retroviruses·1994· 343 cited
A fibroblast growth factor-like activity secreted by a human B-cell line
Cytokine·1994
Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS
Journal of Virology·1994· 281 citedOpen Access
Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization
AIDS Research and Human Retroviruses·1994· 525 cited
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Journal of Virology·1993· 985 citedOpen Access
Isolation of isoproteins from monoclonal antibodies and recombinant proteisn by chromatofocusing
Journal of Chromatography A·1990· 20 cited
page 1 of 2Next →

Frequent Co-authors

Franz Steindl(9), Alexandra Trkola(8), Andrea Buchacher(7), Hermann Katinger(7), Thomas Muster(5), H. Katinger(5), A. Klima(5), Christa Tauer(5), Gerhard Grüber(4), Alois Jungbauer(4), Peter L. Turecek(4), Artur Mitterer(4), Herbert Gritsch(3), Katalin Váradi(3), John P. Moore(2), Florian Rüker(2), RENATE PREDL(2), Renate Kunert(2), Rudolf Berger(2), Peter Palese(2)